<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00328419</url>
  </required_header>
  <id_info>
    <org_study_id>2004.358</org_study_id>
    <nct_id>NCT00328419</nct_id>
  </id_info>
  <brief_title>Consequences of Parenteral Nutrition Photoprotection on Oxidant Related Diseases Among Extremely Low Birth Weight Infants</brief_title>
  <official_title>Consequences of Parenteral Nutrition Photoprotection on the Oxidant Related Diseases Among Extremely Low Birth Weight Infants : A Randomized Controlled Study</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Hospices Civils de Lyon</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Hospices Civils de Lyon</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The antioxidant system of very low birth weight infants is immature. This immaturity is
      implicated in the pathogenesis of diseases such as bronchopulmonary dysplasia or retinopathy.
      The main source of oxidant is oxygen, and parenteral nutrition is contaminated with oxidant.
      Photoprotection decreases the oxidant load infused with parenteral nutrition. In a
      preliminary study, photoprotection reduced the frequency of pulmonary bronchodysplasia,
      increased the quantity of enteral nutrition tolerated, and decreased the arterial blood
      pressure among very low birth weight infants. The aim of this study is to evaluate the impact
      of photoprotection on oxidant related diseases among very low birth weight infants. This
      study is a randomized multicenter trial. In the intervention group, photoprotection is
      applied until the infusion of parenteral nutrition with amber bags, tubing, and syringes. The
      quality of photoprotection is controlled by measuring malondialdehyde and cysteine after 24
      hours of infusion. The control group will receive parenteral nutrition with transparent bags
      and tubing. The outcomes are evaluated at 36 weeks, and 680 infants will be enrolled, with
      stratification among centers and gestational age.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>May 2006</start_date>
  <completion_date type="Actual">May 2010</completion_date>
  <primary_completion_date type="Actual">April 2010</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Prevention</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Death or bronchopulmonary dysplasia at 28 days</measure>
    <time_frame>28 days</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Retinopathy of prematurity</measure>
    <time_frame>36 weeks</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>sepsis</measure>
    <time_frame>28 days and 36 weeks</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>intraventricular hemorrhage</measure>
    <time_frame>7 days, 24days, 36 weeks</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>periventricular leucomalacia</measure>
    <time_frame>36 weeks</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>tolerance of enteral nutrition</measure>
    <time_frame>during enteral nutrition</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>enterocolitis</measure>
    <time_frame>36 weeks</time_frame>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">591</enrollment>
  <condition>Infant, Premature</condition>
  <arm_group>
    <arm_group_label>1</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>photoprotected parenteral nutrition</description>
  </arm_group>
  <arm_group>
    <arm_group_label>2</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Non-photoprotected parenteral nutrition</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>photoprotected bags, tubing, syringes</intervention_name>
    <description>use of photoprotected parenteral nutrition device</description>
    <arm_group_label>1</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>standard tubing and bags</intervention_name>
    <description>Use of standard (transparent) parenteral nutrition device</description>
    <arm_group_label>2</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Infants born before 30 weeks gestational age

          -  Postnatal age between 1 and 6 days

          -  Apgar score up to 2

        Exclusion Criteria:

          -  Severe congenital abnormalities

          -  Intraventricular hemorrhage grade up to 2

          -  Proven sepsis before inclusion

          -  Transfusion before inclusion

          -  Use of intravenous lipids or parenteral nutrition before randomisation
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>N/A</minimum_age>
    <maximum_age>6 Days</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Sophie Laborie, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Hospices Civils de Lyon</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Angelique Denis</name>
      <address>
        <city>Lyon</city>
        <zip>69003</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>France</country>
  </location_countries>
  <results_reference>
    <citation>Laborie S, Denis A, Dassieu G, Bedu A, Tourneux P, Pinquier D, Kermorvant E, Millet V, Klosowski S, Patural H, Clamadieu C, Brunhes A, Walther M, Jaisson-Hot I, Mandy B, Claris O. Shielding Parenteral Nutrition Solutions From Light: A Randomized Controlled Trial. JPEN J Parenter Enteral Nutr. 2015 Aug;39(6):729-37. doi: 10.1177/0148607114537523. Epub 2014 Jun 12.</citation>
    <PMID>24925504</PMID>
  </results_reference>
  <verification_date>December 2011</verification_date>
  <study_first_submitted>May 19, 2006</study_first_submitted>
  <study_first_submitted_qc>May 19, 2006</study_first_submitted_qc>
  <study_first_posted type="Estimate">May 22, 2006</study_first_posted>
  <last_update_submitted>May 23, 2019</last_update_submitted>
  <last_update_submitted_qc>May 23, 2019</last_update_submitted_qc>
  <last_update_posted type="Actual">May 28, 2019</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Photoprotection,</keyword>
  <keyword>Parenteral nutrition</keyword>
  <keyword>Oxidant stress</keyword>
  <keyword>Infant, Premature</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Birth Weight</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

